-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L2bXnc6qZyE+m0qVijZC18/jDHEN++SDgDZxBvZu2+SgM9chEhLkA6SrXc3MRFh2 VPxfwI3WT3b7tMKreSDatQ== 0001181431-08-031421.txt : 20080514 0001181431-08-031421.hdr.sgml : 20080514 20080514184115 ACCESSION NUMBER: 0001181431-08-031421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080512 FILED AS OF DATE: 20080514 DATE AS OF CHANGE: 20080514 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUTTER MARTIN P CENTRAL INDEX KEY: 0001017832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 08833446 BUSINESS ADDRESS: STREET 1: 2170 BUCKTHORNE PLACE SUITE 170 CITY: THE WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 7133679999 MAIL ADDRESS: STREET 1: 2170 BUCKTHORNE PLACE STREET 2: SUITE 170 CITY: THE WOODLAND STATE: TX ZIP: 77380 4 1 rrd206851.xml ESSEX'S PURCHASE OF LA JOLLA X0202 4 2008-05-12 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001017832 SUTTER MARTIN P 21 WATERWAY SUITE 225 THE WOODLANDS TX 77380 1 0 0 0 Common Stock 2008-05-12 4 P 0 2081977 1.89 A 9748643 I By Essex Woodlands Health Ventures Fund VI, L.P. Common Stock 64400 D Stock option (right to buy) .69 2015-12-14 Common Stock 40000 40000 D Warrant (right to buy) 0.125 2008-05-12 4 P 0 520494 0.125 D 2008-05-12 Common Stock 2187160 2187160 I By Essex Woodlands Health Ventures Fund VI, L.P. The reporting person is a managing director of the general partner of the general partner of the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The options vest and become exercisable with respect to 25% of the underlying shares on 12/14/2005 and with respect to an additional 25% of the underlying shares on each of the next three annual anniversaries thereof. The right to purchase shares of common stock under the warrant expires upon the earlier of (i) the fifth anniversary of May 12, 2008 and (ii) the date of consummation of any certain extraordinary transactions. /s/ Martin P. Sutter 2008-05-14 -----END PRIVACY-ENHANCED MESSAGE-----